Investment firm Bernstein initiated coverage on Colgate-Palmolive (NYSE: CL) with a Market Perform rating, at a time when the Colgate-Palmolive stock price was $89.39. Colgate-Palmolive is a global company that produces well-known consumer goods, including oral, personal, and home care products. A Market Perform rating suggests the Colgate-Palmolive stock is expected to perform in line with the general market.
The neutral rating reflects Colgate-Palmolive's mixed financial performance. In its first quarter, Colgate-Palmolive reported a solid 8.4% increase in revenue. This revenue growth was primarily driven by strong sales in markets outside of North America, showing the company's international strength. This performance provides a stable foundation for the consumer goods business.
However, the company faces significant challenges in North America, where its operating profit fell by 28%. Operating profit is the income a company generates from its main business activities. This decline is due to margin pressure, which means higher costs from tariffs and freight are reducing the profit made on each sale for Colgate-Palmolive.
To address these cost pressures, Colgate-Palmolive is expanding its productivity program. The company aims to achieve annual pretax savings of $200 million to $300 million by 2028. These strategic savings are expected to come from making its supply chain and general operations more efficient.
Other analysts present a different view. As highlighted by Zacks Investment Research, Colgate-Palmolive holds a #4 (Sell) rating, which contrasts with competitor Ollie's Bargain Outlet's #2 (Buy) rating. With a market capitalization of $71.53 billion, Colgate-Palmolive's stock has traded between a low of $74.55 and a high of $99.33 over the past 52 weeks.
